Finding new osteoarthritis medicines via AI and genetics

AI Summary

Researchers are using AI-driven molecular biology tools combined with genetic studies of Utah families to identify new medications that could treat osteoarthritis at its source. Osteoarthritis remains a chronic painful disease with limited therapies focused mainly on symptom management.

Osteoarthritis (OA) is a chronic, painful joint disease and a leading cause of disability. Despite its prevalence, therapies for osteoarthritis are limited and focus on symptom management. Now, researchers are combining genetic studies of Utah families with AI-based molecular biology tools to find new medications that may ultimately help treat OA at its source.